Photo by John Lamparski | Getty Images
Look up ‘power broker’ in the dictionary, and you might see a picture of Michael Milken. He’s not a global politician or CEO of a huge conglomerate, but his influence can move either of those people and everyone in between.
Milken leads the Milken Institute, which he’s built into one of the most influential platforms in the world for shaping conversations on health, finance, biotech, and public policy. He’s one of the very few people who can pull together CEOs, scientists, policymakers, and philanthropists to tackle big, messy problems. When Milken decides an issue deserves attention, it suddenly finds itself with a roomful of decision-makers behind it.
He’s particularly impactful in medical research and public-health funding, where he’s helped accelerate breakthroughs in cancer, aging, and rare diseases. That gives him credibility across both the scientific and financial worlds, a rare combination.
As governments and companies wrestle with aging populations, biotech innovation, and global capital flows, Milken’s network and agenda-setting power matter more than ever. He doesn’t hold public office, but he often decides who’s in the room when major decisions get made.
